Who is sponsoring NCT05481632?

NCT05481632 is sponsored by Ruijin Hospital.

What drugs are being tested in NCT05481632?

Interventions in NCT05481632: Endoangel assisted the process of colonoscopy, Colonoscopy was performed without endoangel assistance.

What condition does NCT05481632 study?

NCT05481632 studies Intestinal Polyps.

Is NCT05481632 still recruiting?

NCT05481632 is currently completed. Last updated 1 August 2022.

Last reviewed 2022-08-01 · How we verify

NCT05481632

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validating the Safety and Effectiveness of ENDOANGEL Lower Gastrointestinal Endoscope Image Auxiliary Diagnostic Software

Completed NA Last updated 1 August 2022

What this trial tests

NA trial testing Endoangel assisted the process of colonoscopy in Intestinal Polyps in 1,360 participants. Completed in 4 March 2022.

Timeline

17 January 2021

Primary endpoint
16 July 2021

4 March 2022

Quick facts

Lead sponsor	Ruijin Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	1,360
Start date	17 January 2021
Primary completion	16 July 2021
Estimated completion	4 March 2022
Sites	1 location across China

Drugs / interventions tested

Endoangel assisted the process of colonoscopy
Colonoscopy was performed without endoangel assistance

Conditions studied

Intestinal Polyps — all drugs for Intestinal Polyps →

Sponsor

Ruijin Hospital

Who can join

Adults 18 to 75, any sex, with Intestinal Polyps. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the safety and effectiveness of ENDOANGEL Lower Gastrointestinal Endoscope Image Auxiliary Diagnostic Software developed and manufactured by Wuhan ENDOANGEL Medical Technology Co., Ltd.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ruijin Hospital trials

Trials by the same sponsor.

NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05481632 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
Last refreshed: 1 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05481632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing